Links from MedGen
Items: 8
| Gene(s) | Protein change | Condition(s) | Clinical significance (Last reviewed) | Review status |
---|
| - GRCh37:
- ChrMT:4681
- GRCh38:
- ChrMT:4681
| MT-ND2 | | Leigh syndrome due to mitochondrial complex I deficiency | Pathogenic (Nov 1, 2006) | no assertion criteria provided |
| - GRCh37:
- ChrMT:13042
- GRCh38:
- ChrMT:13042
| MT-ND5 | | Mitochondrial disease | Likely pathogenic (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:13513
- GRCh38:
- ChrMT:13513
| MT-ND5 | | Mitochondrial disease | Pathogenic (Oct 26, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:13084
- GRCh38:
- ChrMT:13084
| MT-ND5 | | Leigh syndrome due to mitochondrial complex I deficiency, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic (Jun 10, 2003) | no assertion criteria provided |
| - GRCh37:
- ChrMT:13045
- GRCh38:
- ChrMT:13045
| MT-ND5 | | Leigh syndrome due to mitochondrial complex I deficiency, Leber optic atrophy, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke
| Pathogenic (Jan 1, 2003) | no assertion criteria provided |
| - GRCh37:
- ChrMT:12706
- GRCh38:
- ChrMT:12706
| MT-ND5 | F124L | Mitochondrial disease | Likely pathogenic (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:14487
- GRCh38:
- ChrMT:14487
| MT-ND6 | | Mitochondrial disease | Pathogenic (Aug 8, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:14459
- GRCh38:
- ChrMT:14459
| MT-ND6 | | Mitochondrial disease | Pathogenic (Nov 1, 2021) | reviewed by expert panel FDA Recognized Database |